The protective gene dose effect of the APOEε2 allele on gray matter volume in cognitively unimpaired individuals
Authors:
- Gemma SalvadóGSGemma Salvadó
- Daniel FerreiraDFDaniel Ferreira
- Grégory OpertoGOGrégory Operto
- Irene Cumplido-MayoralICIrene Cumplido-Mayoral
- Eider M. Arenaza-UrquijoEAEider M. Arenaza-Urquijo
- Raffaele CacciagliaRCRaffaele Cacciaglia
- Carles FalconCFCarles Falcon
- Natàlia Vilor-TejedorNVNatàlia Vilor-Tejedor
- Carolina MinguillonCMCarolina Minguillon
- Colin GrootCGColin Groot
- Wiesje M. van der FlierWFWiesje M. van der Flier
- Frederik BarkhofFBFrederik Barkhof
Open Access
- 8 December 2021
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 18 (7) , 1383-1395
Abstract
Introduction: Harboring two copies of the apolipoprotein E (APOE) ε2 allele strongly protects against Alzheimer's disease (AD). However, the effect of this genotype on gray matter (GM) volume in cognitively unimpaired individuals has not yet been described.Methods: Multicenter brain magnetic resonance images (MRIs) from cognitively unimpaired ε2 homozygotes were matched (1:1) against all other APOE genotypes for relevant confounders (n = 223). GM volumes of ε2 genotypic groups were compared to each other and to the reference group (APOE ε3/ε3).Results: Carrying at least one ε2 allele was associated with larger GM volumes in brain areas typically affected by AD and also in areas associated with cognitive resilience. APOE ε2 homozygotes, but not APOE ε2 heterozygotes, showed larger GM volumes in areas related to successful aging.Discussion: In addition to the known resistance against amyloid‐β deposition, the larger GM volumes in key brain regions may confer APOE ε2 homozygotes additional protection against AD‐related cognitive decline.Keywords
Funding Information
- Vetenskapsrådet (2016‐02282, 2016‐00906, 2019‐02075)
- Hjärnfonden (FO2019‐0326)
- Åke Wiberg Stiftelse
- Olle Engkvists Stiftelse
This publication has 46 references indexed in Scilit:
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNature Reviews Neurology, 2013
- Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adultsNeurobiology of Aging, 2012
- Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β PeptideThe Journal of Neuroscience, 2012
- Basic statistical analysis in genetic case-control studiesNature Protocols, 2011
- Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adultsNeuroscience Letters, 2010
- Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapyNature Reviews Neuroscience, 2009
- APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest oldNeurology, 2009
- The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive IndividualsCerebral Cortex, 2008
- Dissociation of Neuropathologic Findings and CognitionArchives of Neurology, 2007